Gut microbiota in early pediatric multiple sclerosis: a case-control study/Experiment 2/Signature 2
From BugSigDB
Reviewed Marked as Reviewed by Atrayees on 2023-6-30
Source: Figure 2b
Description: Difference between multiple sclerosis and controls influenced by the immunomodulatory drug IMD exposure status of cases
Abundance in Group 1: decreased abundance in IMD exposure multiple sclerosis cases
NCBI | Quality Control | Links |
---|---|---|
Mycoplasmatota | ||
Cyanobacteriota |
Revision editor(s): WikiWorks